ECRC
Minneapolis, Minnesota, 55454, United States
NCT Number: NCT02800707
This study will determine the influence of two non-caloric sweeteners on glucose metabolism via the gut microbiome in adult men and women.
Looking for future studies?
Notify Me35 year–55 year
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55454, United States
This study will determine the influence of two non-caloric sweeteners on glucose metabolism via the gut microbiome in adult men and women aged 35-55 years.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Generally health adult men and women aged 35-55 years old -
Exclusion criteria
Adults will not be eligible who have chronic disease (cancer, CHD, diabetes, chronic kidney disease); pregnant or breast feeding; menopausal; has a history of bariatric surgery; taking prednisone/steroids, taking medication for PCOS, or take medications that influence blood glucose.
-
Sweetner
Sweetner
Time frame: 14 days
An oral glucose tolerance test will be administered before and after consuming assigned sweetener to determine change in 2-hour glucose
Time frame: 14 days
Gut microbiota will be measured before and after consuming assigned sweetener to determine change in gut microbiota.
University of Minnesota
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04018105
Body Weight, Diabetes Mellitus
View Trial DetailsNCT01864460
Behavior, Diabetes
Baltimore, Maryland, United States
View Trial DetailsNCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT06901076
Glucose Intolerance, Glucose Metabolism Disorders
Pavia, Italy
View Trial Details